Trial · NCT02966834
Participant flow54
How many started, completed or left each group, period by period.
1 to 20 of 54
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Main Study Period (Up to 12 Weeks) | STARTED | Placebo | 36 | |
| Main Study Period (Up to 12 Weeks) | STARTED | GSK2330672 20 mg QD | 16 | |
| Main Study Period (Up to 12 Weeks) | STARTED | GSK2330672 90 mg QD | 23 | |
| Main Study Period (Up to 12 Weeks) | STARTED | GSK2330672 180 mg QD | 27 | |
| Main Study Period (Up to 12 Weeks) | STARTED | GSK2330672 40 mg BID | 23 | |
| Main Study Period (Up to 12 Weeks) | STARTED | GSK2330672 90 mg BID | 22 | |
| Main Study Period (Up to 12 Weeks) | COMPLETED | Placebo | 35 | |
| Main Study Period (Up to 12 Weeks) | COMPLETED | GSK2330672 20 mg QD | 16 | |
| Main Study Period (Up to 12 Weeks) | COMPLETED | GSK2330672 90 mg QD | 19 | |
| Main Study Period (Up to 12 Weeks) | COMPLETED | GSK2330672 180 mg QD | 19 | |
| Main Study Period (Up to 12 Weeks) | COMPLETED | GSK2330672 40 mg BID | 22 | |
| Main Study Period (Up to 12 Weeks) | COMPLETED | GSK2330672 90 mg BID | 17 | |
| Main Study Period (Up to 12 Weeks) | NOT COMPLETED | Placebo | 1 | |
| Main Study Period (Up to 12 Weeks) | NOT COMPLETED | GSK2330672 20 mg QD | 0 | |
| Main Study Period (Up to 12 Weeks) | NOT COMPLETED | GSK2330672 90 mg QD | 4 | |
| Main Study Period (Up to 12 Weeks) | NOT COMPLETED | GSK2330672 180 mg QD | 8 | |
| Main Study Period (Up to 12 Weeks) | NOT COMPLETED | GSK2330672 40 mg BID | 1 | |
| Main Study Period (Up to 12 Weeks) | NOT COMPLETED | GSK2330672 90 mg BID | 5 | |
| Final Study Period (Up to 4 Weeks) | STARTED | Placebo | 35 | |
| Final Study Period (Up to 4 Weeks) | STARTED | GSK2330672 20 mg QD | 16 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02966834/flow